Explained herein are pharmaceutical packaging programs which protect against oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-delicate drugs, these devices which include a syringe by having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with incredibly small permeability to